San Diego, CA – In a groundbreaking move, Provisio Medical, Inc. has announced the establishment of a Physician Advisory Board (PAB) that aims to revolutionize endovascular interventions. The board, consisting of leading experts in vascular surgery, interventional radiology, and interventional cardiology, will provide valuable insights into product development, clinical studies, and the therapeutic applications of Provisio’s Sonic Lumen Tomography™ Intravascular Ultrasound (SLT IVUS™) technology.
With approximately 20 million individuals in the United States alone affected by peripheral artery disease (PAD), the need for innovative solutions is more pressing than ever. Provisio’s SLT IVUS addresses this unmet need by offering automatic, real-time, and accurate measurements of blood vessels’ flow lumen without the complexities of image interpretation. By combining intravascular imaging, support crossing catheter technology, and the delivery of contrast agents, Provisio’s catheter represents a major leap forward in endovascular procedures.
“We are thrilled to have such esteemed physicians on our Physician Advisory Board,” says Dr. S. Eric Ryan, CEO of Provisio Medical. “Their diverse backgrounds and clinical expertise will be invaluable in guiding our strategic decisions and drive further advancements in the field of endovascular interventions.”
One board member, Dr. Zola N’Dandu, expresses excitement over the collaboration, stating, “Working closely with Provisio Medical on the development of SLT IVUS technology allows us to push the boundaries of medical innovation and enhance patient care. I look forward to collaborating with colleagues from various specialties to achieve this mission.”
Precision in endovascular techniques plays a crucial role in determining successful outcomes. Current practices often lack the necessary precision, hindering progress in the field. However, with Provisio’s SLT IVUS technology, clinicians gain enhanced visibility and access to precise measurements, ultimately transforming outcomes and furthering our understanding of therapeutic approaches.
Provisio Medical, based in San Diego, California, aims to set a new standard in vessel sizing for endovascular procedures. Their SLT IVUS technology, integrated into commonly used catheters, has the potential to revolutionize interventional therapies by providing physicians with accurate and timely information, ultimately improving procedural workflow and patient care.
For more information, visit their website at www.provisiomedical.com.
Exciting Advances in Vascular Imaging for Improved Patient Care
In addition to the information provided in the article, there are several current market trends and forecasts in the field of vascular imaging that are worth mentioning.
One of the key trends is the increasing demand for minimally invasive procedures. As patients seek less invasive options for diagnosis and treatment, there is a growing need for advanced imaging technologies that can provide accurate and detailed information without the need for invasive procedures. This is particularly important in the field of vascular imaging, where precision is essential.
Another trend is the adoption of artificial intelligence (AI) in vascular imaging. AI algorithms can analyze large amounts of data and help detect abnormalities or identify patterns that may not be easily recognizable to the human eye. This can aid in early diagnosis and more effective treatment planning.
In terms of forecasts, the vascular imaging market is expected to witness significant growth in the coming years. Factors such as the increasing prevalence of cardiovascular diseases, technological advancements in imaging techniques, and the rising demand for personalized medicine are driving this growth. According to a report by Grand View Research, the global vascular imaging market is projected to reach USD 27.8 billion by 2025, with a compound annual growth rate (CAGR) of 6.4% during the forecast period.
However, there are also key challenges and controversies associated with vascular imaging technology. One challenge is the cost of implementing advanced imaging technologies, which may limit their accessibility to some healthcare facilities. Additionally, there is an ongoing debate about the potential risks of exposing patients to contrast agents used in imaging procedures, particularly for individuals with kidney problems.
Advantages of Provisio’s SLT IVUS technology mentioned in the article include automatic, real-time, and accurate measurements of blood vessels’ flow lumen without the complexities of image interpretation. This provides clinicians with enhanced visibility and access to precise measurements, ultimately transforming outcomes and furthering our understanding of therapeutic approaches.
A disadvantage that could be mentioned is that integrating SLT IVUS into commonly used catheters may require additional training for healthcare professionals or may add to the overall cost of the procedure.
For more information on Provisio Medical and their SLT IVUS technology, visit their website at www.provisiomedical.com.